Age at Occurrence of Exudative Age-Related Macular Degeneration in a Clinical Setting: Difference between 1986 and 2006

Publisher： Karger

E-ISSN： 1423-0267|225|2|76-80

ISSN： 0030-3755

Source： Ophthalmologica, Vol.225, Iss.2, 2010-09, pp. : 76-80

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intravitreal Ranibizumab in Daily Clinical Practice for Age-Related Macular Degeneration: Treatment of Exudative Age-Related Macular Degeneration in Real Life

By  

Ophthalmologica, Vol. 234, Iss. 1, 2015-06 ,pp. : 26-32

Karger

Access to resources Recommend Favorite

Repeated Intravitreal Injection of Triamcinolone for Exudative Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 38, Iss. 6, 2006-11 ,pp. : 324-328

Karger

Access to resources Recommend Favorite

Detection of Antiranibizumab Antibodies among Patients with Exudative Age-Related Macular Degeneration

By  

Ophthalmologica, Vol. 232, Iss. 1, 2014-05 ,pp. : 53-56

Karger

Access to resources Recommend Favorite

Intravitreal Bevacizumab versus Triamcinolone Acetonide for Exudative Age-Related Macular Degeneration

By  

Ophthalmic Research, Vol. 41, Iss. 1, 2008-10 ,pp. : 21-27

Karger

Access to resources Recommend Favorite

Treatment of Exudative Age-Related Macular Degeneration with Intravitreal Ranibizumab in Clinical Practice: A 3-Year Follow-Up

By  

Ophthalmologica, Vol. 229, Iss. 3, 2013-03 ,pp. : 158-167

Karger

Access to resources Recommend Favorite